Canadian-made Ebola vaccine starting clinical trials in humans

Health Minister Rona Ambrose said trials are moving at “unprecedented speeds,” but critics slam government for not acting faster amid deadly outbreak.Clinical trials are now starting for an experimental made-in-Canada Ebola vaccine amid growing global concern over the disease that’s left more than 4,000 people dead.Federal Health Minister Rona Ambrose called...

Read More

New portal showcases Canadian clinical research capabilities

Ottawa, ON – The Canadian Clinical Trials Coordinating Centre (CCTCC) has launched the Canadian Clinical Trials Asset Map, a pan-Canadian database showcasing Canada’s clinical research capacities. Intended to help Canada regain its position as a leading destination for clinical trials, the online portal provides a comprehensive picture of Canada’s clinical research assets...

Read More

Canadian Clinical Trials Asset Map was launched by researchers

The Canadian Clinical Trials Asset Map was launched by researchers, industry leaders and policy-makers including, left to right, Dr. Shurjeel Choudhri, Bayer Inc., Belinda Vandersluis, director of the Canadian Clinical Trials Coordinating Centre, and Senator Kelvin Ogilvie. Canada is aiming to regain its research edge through a new national database highlighting...

Read More

Synergy Pharmaceuticals Initiates Second Phase 3 Clinical Trial of Plecanatide in Patients with IBS with Constipation

NEW YORK, June 23, 2015 — Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) announced today the initiation of the second of two pivotal phase 3 clinical trialsevaluating the efficacy and safety of two different plecanatide treatment doses (3.0 mg and 6.0 mg), taken as a tablet once-a-day, in patients with irritable bowel syndrome with constipation (IBS-C). The phase 3...

Read More

Investing in hepatitis C drugs could save the economy billions, researchers suggest

by Catharine Paddock PhD Medical News Today Researchers who examined the effect of treating hepatitis C patients with the newer generation of oral drugs suggest while these medications may cost tens of thousands of dollars for a 12-week course, they could avert billions in lost productivity. They conclude that the higher cure rate and reduced side effects of treating...

Read More

Hepatitis C treatments are ‘history in the making’ at a high cost !!

BillyBob McPherson lived on Ottawa’s streets as a young teenager before “running away with the carnival.” The 55-year-old doesn’t know exactly when during his colourful life he contracted hepatitis C — he thinks it might have been in Texas in the 1980s where he had surgery and blood transfusions while working as a carny. But without treatment, he believes, the disease...

Read More